Glycemic variability determined by continuous glucose monitoring system predicts left ventricular remodeling in patients with a first ST-segment elevation myocardial infarction

Circulation Journal

Volumn 79, Issue 5, 2015, Pages 1092-1099

  Gohbara, Masaomi ^a   Iwahashi, Noriaki ^a   Kataoka, Shunsuke ^a   Hayakawa, Yoshikazu ^a   Sakamaki, Kentaro ^a   Akiyama, Eiichi ^a   Maejima, Nobuhiko ^a   Tsukahara, Kengo ^a   Hibi, Kiyoshi ^a   Kosuge, Masami ^a   Ebina, Toshiaki ^a   Umemura, Satoshi ^b   Kimura, Kazuo ^a  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; Continuous glucose monitoring system; Glucose; Glycemic variability; Remodeling

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CARDIOVASCULAR MAGNETIC RESONANCE; CONTINUOUS GLUCOSE MONITORING SYSTEM; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART VENTRICLE REMODELING; HUMAN; LEFT VENTRICULAR REMODELING; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEAN AMPLITUDE OF GLYCEMIC EXCURSION; METABOLIC PARAMETERS; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; BLOOD; CLINICAL TRIAL; HEART INFARCTION; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RADIOGRAPHY;

AGED; BLOOD GLUCOSE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; VENTRICULAR REMODELING;

EID: 84928492217     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-14-1226     Document Type: Article

References (33)

1. Bando YK, Murohara T. Diabetes-related heart failure. Circ J 2014; 78: 576-583.
2. Zuanetti G, Latini R, Maggioni AP, Santoro L, Franzosi MG. Influence of diabetes on mortality in acute myocardial infarction: Data from the GISSI-2 study. J Am Coll Cardiol 1993; 22: 1788-1794.
3. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: A prospective study. Circulation 2005; 111: 754-760.
4. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: Implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078-3086.
5. Yang SW, Zhou YJ, Hu DY, Nie XM, Liu YY, Hua Q, et al. Association between admission hypoglycaemia and in-hospital and 3-year mortality in older patients with acute myocardial infarction. Heart 2010; 96: 1444-1450.
6. Timmer JR, Hoekstra M, Nijsten MW, van der Horst IC, Ottervanger JP, Slingerland RJ, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segmentelevation myocardial infarction treated with percutaneous coronary intervention. Circulation 2011; 124: 704-711.
7. Wang X, Zhao X, Dorje T, Yan H, Qian J, Ge J. Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus. Int J Cardiol 2014; 172: 498-500.
8. D’Archangelo MJ. New guideline supports the development and evaluation of continuous interstitial glucose monitoring devices. J Diabetes Sci Technol 2008; 2: 332-334.
9. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
10. Aletras AH, Tilak GS, Natanzon A, Hsu LY, Gonzalez FM, Hoyt RF, et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006; 113: 1865-1870.
11. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013; 36(Suppl 1): S67-S74.
13. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of postmyocardial infarction mortality. Circulation 2006; 114: 32-39.
14. Kitabata H, Kubo T, Ishibashi K, Komukai K, Tanimoto T, Ino Y, et al. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2013; 6: 1046-1054.
15. Lund GK, Stork A, Muellerleile K, Barmeyer AA, Bansmann MP, Knefel M, et al. Prediction of left ventricular remodeling and analysis of infarct resorption in patients with reperfused myocardial infarcts by using contrast-enhanced MR imaging. Radiology 2007; 245: 95-102.
16. Springeling T, Kirschbaum SW, Rossi A, Baks T, Karamermer Y, Schulz C, et al. Late cardiac remodeling after primary percutaneous coronary intervention-five-year cardiac magnetic resonance imaging follow-up. Circ J 2013; 77: 81-88.
17. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Serum c-reactive protein elevation in left ventricular remodeling after acute myocardial infarction: Role of neurohormones and cytokines. Int J Cardiol 2003; 88: 257-265.
18. Stettler C, Allemann S, Juni P, Cull CA, Holman RR, Egger M, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 2006; 152: 27-38.
19. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
20. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
21. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 2003; 52: 2795-2804.
22. JCS Joint Working Group. Guidelines for secondary prevention of myocardial infarction (JCS 2011): Digest version. Circ J 2013; 77: 231-248.
23. Lipska KJ, Venkitachalam L, Gosch K, Kovatchev B, Van den Berghe G, Meyfroidt G, et al. Glucose variability and mortality in patients hospitalized with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2012; 5: 550-557.
24. Sampaio CR, Franco DR, Goldberg DJ, Baptista J, Eliaschewitz FG. Glucose control in acute myocardial infarction: A pilot randomized study controlled by continuous glucose monitoring system comparing the use of insulin glargine with standard of care. Diabetes Technol Ther 2012; 14: 117-124.
25. Teraguchi I, Imanishi T, Ozaki Y, Tanimoto T, Ueyama M, Orii M, et al. Acute-phase glucose fluctuation is negatively correlated with myocardial salvage after acute myocardial infarction. Circ J 2013; 78: 170-179.
26. Carrabba N, Valenti R, Parodi G, Santoro GM, Antoniucci D. Left ventricular remodeling and heart failure in diabetic patients treated with primary angioplasty for acute myocardial infarction. Circulation 2004; 110: 1974-1979.
27. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1-7.
28. Werner GS, Richartz BM, Heinke S, Ferrari M, Figulla HR. Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 2003; 24: 1134-1142.
29. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Nishioka K, et al. Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 2001; 38: 1007-1011.
30. Choi KM, Lee KW, Kim SG, Kim NH, Park CG, Seo HS, et al. Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus. J Clin Endocrinol Metab 2005; 90: 175-180.
31. Suarez J, Hu Y, Makino A, Fricovsky E, Wang H, Dillmann WH. Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes. Am J Physiol Cell Physiol 2008; 295: C1561-C1568.
32. Rizzo MR, Barbieri M, Marfella R, Paolisso G. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: Role of dipeptidyl peptidase-IV inhibition. Diabetes Care 2012; 35: 2076-2082.
33. Ozasa N, Kimura T, Morimoto T, Hou H, Tamura T, Shizuta S, et al. Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol 2010; 106: 1225-1233.